INTERNATIONAL SOCIETY OF GLOMERULAR DISEASE (EIN 922269671) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2022

Legal Domicile

Principal Officer

LAUREL DAMASHEK

Phone

6172862025

Tax Period

2024-01-01 to 2024-12-31

INTERNATIONAL SOCIETY OF GLOMERULAR DISEASE, founded in 2022, is a small nonprofit in the Diseases & Disorders sector that reported $655K in total revenue in fiscal year 2024. Revenue grew 14% year-over-year, indicating healthy expansion. Expenses of $579K left a modest 12% surplus.

Mission

THE INTERNATIONAL SOCIETY OF GLOMERULAR DISEASE IS A MEDICAL SOCIETY FOUNDED IN 2022 TO PROVIDE A PHYSICIAN AND RESEARCHER CENTRIC PROFESSIONAL HOME FOR GLOMERULAR DISEASE EXPERTS. ISGD WAS INITIALLY ENVISIONED BY NEPHCURE AND ITS NETWORK OF GLOMERULAR HEALTH LEADERS. IT IS NOW AN INDEPENDENT NON PROFIT 501(C)(6) ORGANIZATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $651,650

Program Service Revenue $0

Investment Income $3,270

Other Revenue $0

TOTAL REVENUE $654,920

Expense Breakdown

Grants Paid $0

Salaries & Benefits $309,106

Fundraising Expenses $0

Program Expenses $427,179

Other Expenses $270,294

TOTAL EXPENSES $579,400

Year-over-Year Comparison

	2024	2023	Change
Revenue	$654,920	$576,023	+0.1%
Expenses	$579,400	$403,435	+0.4%
Net Income	$75,520	$172,588	-0.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$145,879

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LAUREL J DAMASHEK	EXECUTIVE DIRECTOR	40.00	Officer	$140,268	$5,611	$145,879
IRVING SMOKLER	BOARD CHAIR	1.00	Officer	$0	$0	$0
JOSHUA TARNOFF	SECRETARY	1.00	Officer	$0	$0	$0
SHARON ADLER	TREASURER	1.00	Officer	$0	$0	$0
TOBIAS B HUBER	SOCIETY PRESIDENT	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$654,920	$579,400	$546,458	$75,520
2023	$576,023	$403,435	$190,660	$172,588

INTERNATIONAL SOCIETY OF GLOMERULAR DISEASE